These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24673534)

  • 21. Polymorphism of the G protein β3 subunit gene influences the efficacy of sildenafil in patients with pulmonary hypertension.
    Sekine A; Tanabe N; Sugiura T; Shigeta A; Jujo T; Nishimura R; Sakao S; Kasahara Y; Tatsumi K
    Intern Med; 2014; 53(4):291-7. PubMed ID: 24531084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sildenafil therapy for neonatal and childhood pulmonary hypertensive vascular disease.
    Humpl T; Reyes JT; Erickson S; Armano R; Holtby H; Adatia I
    Cardiol Young; 2011 Apr; 21(2):187-93. PubMed ID: 21138617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy and safety of sildenafil therapy in pulmonary artery hypertension: a meta-analysis].
    Kuang TG; Wang J; Zhai ZG; Guo XH; Wang C
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1021-4. PubMed ID: 17672963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety, tolerability, and efficacy of overnight switching from sildenafil to tadalafil in patients with pulmonary arterial hypertension.
    Shapiro S; Traiger G; Hill W; Zhang L; Doran AK
    Cardiovasc Ther; 2013 Oct; 31(5):274-9. PubMed ID: 23841794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sildenafil improves clinical and functional status of an elderly postmenopausal female with 'out of proportion' PH associated with left heart disease.
    Correale M; Totaro A; Ferraretti A; Di Biase M; Brunetti ND
    Monaldi Arch Chest Dis; 2013 Dec; 80(4):193-4. PubMed ID: 25087297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of sildenafil on survival of patients with idiopathic pulmonary arterial hypertension.
    Zeng WJ; Sun YJ; Gu Q; Xiong CM; Li JJ; He JG
    J Clin Pharmacol; 2012 Sep; 52(9):1357-64. PubMed ID: 21956607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sildenafil improves cardiac output and exercise performance during acute hypoxia, but not normoxia.
    Hsu AR; Barnholt KE; Grundmann NK; Lin JH; McCallum SW; Friedlander AL
    J Appl Physiol (1985); 2006 Jun; 100(6):2031-40. PubMed ID: 16455814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphodiesterase type 5 and high altitude pulmonary hypertension.
    Aldashev AA; Kojonazarov BK; Amatov TA; Sooronbaev TM; Mirrakhimov MM; Morrell NW; Wharton J; Wilkins MR
    Thorax; 2005 Aug; 60(8):683-7. PubMed ID: 16061711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sildenafil for enhanced performance at high altitude?
    Rubin LJ; Naeije R
    Ann Intern Med; 2004 Aug; 141(3):233-5. PubMed ID: 15289224
    [No Abstract]   [Full Text] [Related]  

  • 30. Sildenafil citrate, bronchopulmonary dysplasia and disordered pulmonary gas exchange: any benefits?
    Nyp M; Sandritter T; Poppinga N; Simon C; Truog WE
    J Perinatol; 2012 Jan; 32(1):64-9. PubMed ID: 21941230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose response of intravenous sildenafil on systemic and regional hemodynamics in hypoxic neonatal piglets.
    Haase E; Bigam DL; Cravetchi O; Cheung PY
    Shock; 2006 Jul; 26(1):99-106. PubMed ID: 16783205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.
    Montani D; Chaumais MC; Savale L; Natali D; Price LC; Jaïs X; Humbert M; Simonneau G; Sitbon O
    Adv Ther; 2009 Sep; 26(9):813-25. PubMed ID: 19768639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of exercise-induced pulmonary hypertension in patients with cardiac septal defects.
    Brun H; Moller T; Fredriksen PM; Thaulow E; Pripp AH; Holmstrom H
    Pediatr Cardiol; 2012 Jun; 33(5):782-90. PubMed ID: 22383098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sildenafil in the treatment of pulmonary hypertension.
    Barnett CF; Machado RF
    Vasc Health Risk Manag; 2006; 2(4):411-22. PubMed ID: 17323595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sildenafil and an early stage of chronic hypoxia-induced pulmonary hypertension in newborn piglets.
    Binns-Loveman KM; Kaplowitz MR; Fike CD
    Pediatr Pulmonol; 2005 Jul; 40(1):72-80. PubMed ID: 15880376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of statins on erectile dysfunction: a systematic review and meta-analysis.
    Cui Y; Zong H; Yan H; Zhang Y
    J Sex Med; 2014 Jun; 11(6):1367-75. PubMed ID: 24628781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sildenafil therapy for bronchopulmonary dysplasia: not quite yet.
    Farrow KN; Steinhorn RH
    J Perinatol; 2012 Jan; 32(1):1-3. PubMed ID: 22202953
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical study on sildenafil in treatment of pregnant women with pulmonary arterial hypertension].
    Sun X; Wang K; Wang W; Li B
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):414-8. PubMed ID: 25169631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of schistosomiasis-associated pulmonary hypertension.
    Correa Rde A; Moreira MV; Saraiva JM; Mancuzo EV; Silva LC; Lambertucci JR
    J Bras Pneumol; 2011; 37(2):272-6. PubMed ID: 21537664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension.
    Bharani A; Mathew V; Sahu A; Lunia B
    Indian Heart J; 2003; 55(1):55-9. PubMed ID: 12760589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.